✉ Email this page to a colleague
« Back to Dashboard
Acotiamide is an investigational drug.
There have been 6 clinical trials for Acotiamide. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.
The most common disease conditions in clinical trials are Dyspepsia, Gastritis, and [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Zeria Pharmaceutical, and Universitaire Ziekenhuizen Leuven.
Recent Clinical Trials for Acotiamide
|A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia||Zeria Pharmaceutical||Phase 3|
|Helicobacter Pylori Eradication in Functional Dyspepsia||Sir Ganga Ram Hospital||N/A|
|Effect of Acotiamide on Gastric Motility and Satiation in Healthy Volunteers||Universitaire Ziekenhuizen Leuven||N/A|